|
|
|
|
LEADER |
03140nam a22005535i 4500 |
001 |
978-3-540-26980-9 |
003 |
DE-He213 |
005 |
20151204175702.0 |
007 |
cr nn 008mamaa |
008 |
100301s2005 gw | s |||| 0|eng d |
020 |
|
|
|a 9783540269809
|9 978-3-540-26980-9
|
024 |
7 |
|
|a 10.1007/b138402
|2 doi
|
040 |
|
|
|d GrThAP
|
050 |
|
4 |
|a RC1-1245
|
072 |
|
7 |
|a MJ
|2 bicssc
|
072 |
|
7 |
|a MED045000
|2 bisacsh
|
082 |
0 |
4 |
|a 616
|2 23
|
245 |
1 |
0 |
|a Tumor Prevention and Genetics III
|h [electronic resource] /
|c edited by Hans-Jörg Senn, Rudolf Morant.
|
264 |
|
1 |
|a Berlin, Heidelberg :
|b Springer Berlin Heidelberg,
|c 2005.
|
300 |
|
|
|a VI, 334 p.
|b online resource.
|
336 |
|
|
|a text
|b txt
|2 rdacontent
|
337 |
|
|
|a computer
|b c
|2 rdamedia
|
338 |
|
|
|a online resource
|b cr
|2 rdacarrier
|
347 |
|
|
|a text file
|b PDF
|2 rda
|
490 |
1 |
|
|a Recent Results in Cancer Research,
|x 0080-0015 ;
|v 166
|
505 |
0 |
|
|a Lifestyle and Medical Approaches to Cancer Prevention -- Application of Genetics to the Prevention of Colorectal Cancer -- Genetics and Prevention of Oesophageal Adenocarcinoma -- Preclinical Models Relevant to Diet, Exercise, and Cancer Risk -- Individualizing Interventions for Cancer Prevention -- Can Animal Models Help Us Select Specific Compounds for Cancer Prevention Trials? -- Problems with Using Biomarkers as Surrogate End Points for Cancer: A Cautionary Tale -- Can a Marker Be a Surrogate for Development of Cancer, and Would We Know It if It Exists? -- How Should We Move the Field of Chemopreventive Agent Development Forward in a Productive Manner? -- The Problems with Risk Selection; Scientific and Psychosocial Aspects -- Chemoprevention of Lung Cancer -- Anti-nicotine Vaccination: Where Are We? -- Primary Prevention of Colorectal Cancer: Lifestyle, Nutrition, Exercise -- Chemoprevention of Colorectal Cancer: Ready for Routine Use? -- Screening of Colorectal Cancer: Progress and Problems -- The Role of Endogenous Hormones in the Etiology and Prevention of Breast Cancer: The Epidemiological Evidence -- Innovative Agents in Cancer Prevention -- The IARC Commitment to Cancer Prevention: The Example of Papillomavirus and Cervical Cancer -- Health Economics in the Genomic Age -- Screening for Cancer: Are Resources Being Used Wisely?.
|
650 |
|
0 |
|a Medicine.
|
650 |
|
0 |
|a Human genetics.
|
650 |
|
0 |
|a Gynecology.
|
650 |
|
0 |
|a Internal medicine.
|
650 |
|
0 |
|a Gastroenterology.
|
650 |
|
0 |
|a Respiratory organs
|x Diseases.
|
650 |
|
0 |
|a Oncology.
|
650 |
1 |
4 |
|a Medicine & Public Health.
|
650 |
2 |
4 |
|a Internal Medicine.
|
650 |
2 |
4 |
|a Oncology.
|
650 |
2 |
4 |
|a Human Genetics.
|
650 |
2 |
4 |
|a Gynecology.
|
650 |
2 |
4 |
|a Gastroenterology.
|
650 |
2 |
4 |
|a Pneumology/Respiratory System.
|
700 |
1 |
|
|a Senn, Hans-Jörg.
|e editor.
|
700 |
1 |
|
|a Morant, Rudolf.
|e editor.
|
710 |
2 |
|
|a SpringerLink (Online service)
|
773 |
0 |
|
|t Springer eBooks
|
776 |
0 |
8 |
|i Printed edition:
|z 9783540222286
|
830 |
|
0 |
|a Recent Results in Cancer Research,
|x 0080-0015 ;
|v 166
|
856 |
4 |
0 |
|u http://dx.doi.org/10.1007/b138402
|z Full Text via HEAL-Link
|
912 |
|
|
|a ZDB-2-SME
|
950 |
|
|
|a Medicine (Springer-11650)
|